納芯微(688052.SH):單通道/三通道/12通道尾燈LED驅動芯片已經導入汽車車燈頭部客户
格隆匯1月17日丨納芯微(688052.SH)披露投資者關係活動記錄表顯示,車燈驅動方面,公司推出的單通道/三通道/12通道尾燈LED驅動芯片已經導入汽車車燈頭部客户,並且實現大規模出貨;馬達驅動方面,公司在2023年第三季度也陸續量產了新一代隔離半橋驅動以及多路半橋馬達驅動產品,並且開始逐步上量和貢獻增量營收;供電電源LDO方面,公司已經實現部分客户的導入工作,2024年有望逐步貢獻增量營收;功率路徑保護方面,公司低邊開關產品已經實現量產,高邊開關相關產品將於2024年實現量產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.